Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
50.42
+0.27 (0.54%)
At close: Aug 8, 2025, 4:00 PM
51.01
+0.59 (1.17%)
After-hours: Aug 8, 2025, 7:05 PM EDT
Bio-Techne Market Cap
Bio-Techne has a market cap or net worth of $7.90 billion as of August 8, 2025. Its market cap has decreased by -35.37% in one year.
Market Cap
7.90B
Enterprise Value
8.19B
1-Year Change
-35.37%
Ranking
Category
Stock Price
$50.42
Market Cap Chart
Since December 1, 1998, Bio-Techne's market cap has increased from $355.80M to $7.90B, an increase of 2,121.53%. That is a compound annual growth rate of 12.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 7.90B | -30.94% |
Dec 31, 2024 | 11.45B | -6.21% |
Dec 29, 2023 | 12.20B | -6.20% |
Dec 30, 2022 | 13.01B | -36.00% |
Dec 31, 2021 | 20.33B | 65.81% |
Dec 31, 2020 | 12.26B | 46.55% |
Dec 31, 2019 | 8.37B | 53.07% |
Dec 31, 2018 | 5.47B | 12.61% |
Dec 29, 2017 | 4.85B | 26.50% |
Dec 30, 2016 | 3.84B | 14.62% |
Dec 31, 2015 | 3.35B | -2.30% |
Dec 31, 2014 | 3.43B | -1.84% |
Dec 31, 2013 | 3.49B | 38.67% |
Dec 31, 2012 | 2.52B | -0.35% |
Dec 30, 2011 | 2.53B | 3.71% |
Dec 31, 2010 | 2.44B | -4.63% |
Dec 31, 2009 | 2.55B | 4.09% |
Dec 31, 2008 | 2.45B | -6.00% |
Dec 31, 2007 | 2.61B | 19.52% |
Dec 29, 2006 | 2.18B | 0.16% |
Dec 30, 2005 | 2.18B | 35.65% |
Dec 31, 2004 | 1.61B | 3.50% |
Dec 31, 2003 | 1.55B | 31.15% |
Dec 31, 2002 | 1.18B | -22.59% |
Dec 31, 2001 | 1.53B | 2.30% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 561.67B |
Johnson & Johnson | 417.44B |
AbbVie | 349.87B |
Abbott Laboratories | 233.71B |
AstraZeneca | 227.85B |
UnitedHealth Group | 227.59B |
Novartis AG | 225.61B |
Novo Nordisk | 224.34B |